Spondyloarthropathies

American Family Physician

Volumn 69, Issue 12, 2004, Pages 2853-2860

  Kataria, Rajesh K ^a,b   Brent, Lawrence H ^a,c  

^a ALBERT EINSTEIN MEDICAL CENTER   (United States)

^b Cumberland Medical Associates PA   (United States)

^c Einstein Arthritis Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ETANERCEPT; HLA B27 ANTIGEN; INFLIXIMAB; METHOTREXATE; NONSTEROID ANTIINFLAMMATORY AGENT; PAMIDRONIC ACID; SALAZOSULFAPYRIDINE; TUMOR NECROSIS FACTOR ALPHA CONVERTING ENZYME INHIBITOR;

ANKYLOSING SPONDYLITIS; CLINICAL TRIAL; EARLY DIAGNOSIS; ENTERITIS; GENE; HUMAN; PSORIATIC ARTHRITIS; REACTIVE ARTHRITIS; REITER SYNDROME; REVIEW; SPONDYLOARTHROPATHY;

ARTHRITIS, PSORIATIC; DIAGNOSIS, DIFFERENTIAL; HUMANS; INFLAMMATORY BOWEL DISEASES; REITER SYNDROME; SPONDYLITIS; SPONDYLITIS, ANKYLOSING;

EID: 3042704592     PISSN: 0002838X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (31)

1. Gladman DD. Psoriatic arthritis. Rheum Dis Clin North Am 1998;24:829-44.
2. De Keyser F, Elewaut D, De Vos M, De Vlam K, Cuvelier C, Mielants H, et al. Bowel inflammation and the spondyloarthropathies. Rheum Dis Clin North Am 1998;24:785-813,ix-x.
3. Gladman D. Spondyloarthropathies. In: Lahita R, Weinstein A, eds. Educational review manual in rheumatology. 2d ed. rev. New York: Castle Connolly Graduate Medical, 2002:1-26.
4. Van der Linden S, van der Heijde D. Ankylosing spondylitis. Clinical features. Rheum Dis Clin North Am 1998;24:663-76,vii.
5. Van der Linden S, van der Heijde D. Ankylosing spondylitis. In: Ruddy S, Harris ED Jr, Sledge CB, eds. Kelley's Textbook of rheumatology. 6th ed. Philadelphia: Saunders, 2001:1039-54.
6. Calin A, Porta J, Fries JF, Schurman DJ. Clinical history as a screening test for ankylosing spondylitis. JAMA 1977;237:2613-4.
7. Sieper J, Braun J, Rudwaleit M, Boonen A, Zink A. Ankylosing spondylitis: an overview. Ann Rheum Dis 2002;61(suppl 3):iii8-18.
8. Dougados M, Dijkmans B, Khan M, Maksymowych W, van der Linden S, Brandt J. Conventional treatments for ankylosing spondylitis. Ann Rheum Dis 2002;61 (suppl 3):iii40-50.
9. Ferraz MB, Tugwell P, Goldsmith CH, Atra E. Meta-analysis of sulfasalazine in ankylosing spondylitis. J Rheumatol 1990;17:1482-6.
10. Dougados M, van der Linden S, Leirisalo-Repo M, Huitfeldt B, Juhlin R, Veys E, et al. Sulfasalazine in the treatment of spondyloarthropathy. A randomized, multicenter, double-blind, placebo-controlled study. Arthritis Rheum 1995;38:618-27.
11. Clegg DO, Reda DJ, Weisman MH, Blackburn WD, Cush JJ, Cannon GW, et al. Comparison of sulfasalazine and placebo in the treatment of ankylosing spondylitis. A Department of Veterans Affairs Cooperative Study. Arthritis Rheum 1996;39:2004-12.
12. Sampaio-Barros PD, Costallat LT, Bertolo MB, Neto JF, Samara AM. Methotrexate in the treatment of ankylosing spondylitis. Scand J Rheumatol 2000;29:160-2.
13. Maksymowych WP, Jhangri GS, Fitzgerald AA, LeClercq S, Chiu P, Yan A, et al. A six-month randomized, controlled, double-blind, dose-response comparison of intravenous pamidronate (60 mg versus 10 mg) in the treatment of nonsteroidal antiinflammatory drug-refractory ankylosing spondylitis. Arthritis Rheum 2002;46:766-73.
14. Gorman JD, Sack KE, Davis JC Jr. Treatment of ankylosing spondylitis by inhibition of tumor necrosis factor alpha. N Engl J Med 2002;346:1349-56.
15. Davis JC Jr, van der Heijde D, Braun J, Dougados M, Cush J, Clegg DO, et al. Recombinant human tumor necrosis factor receptor (etanercept) for treating ankylosing spondylitis: a randomized, controlled trial. Arthritis Rheum 2003;48:3230-6.
16. Braun J, Brandt J, Listing J, Zink A, Alten R, Golder W, et al. Treatment of active ankylosing spondylitis with infliximab: a randomised controlled multicentre trial. Lancet 2002;359:1187-93.
17. Braun J, Sieper J, Breban M, Collantes-Estevez E, Davis J, Inman R, et al. Anti-tumour necrosis factor alpha therapy for ankylosing spondylitis: international experience. Ann Rheum Dis 2002;61(suppl 3):iii51-60.
18. Braun J, Pham T, Sieper J, Davis J, van der Linden S, Dougados M, et al. International ASAS consensus statement for the use of anti-tumour necrosis factor agents in patients with ankylosing spondylitis. Ann Rheum Dis 2003;62:817-24.
19. Amor B. Reiter's syndrome. Diagnosis and clinical features. Rheum Dis Clin North Am 1998;24:677-95,vii.
20. Yu DT, Peng TF. Reiter's syndrome. In: Ruddy S, Harris ED Jr, Sledge CB, eds. Kelley's Textbook of rheumatology. 6th ed. Philadelphia: Saunders, 2001:1055-70.
21. Lau CS, Burgos-Vargas R, Louthrenoo W, Mok MY, Wordsworth P, Zeng QY. Features of spondyloarthropathies around the world. Rheum Dis Clin North Am 1998;24:753-70.
22. Clegg DO, Reda DJ, Weisman MH, Cush JJ, Vasey FB, Schumacher HR Jr, et al. Comparison of sulfasalazine and placebo in the treatment of reactive arthritis (Reiter's syndrome). A Department of Veterans Affairs Cooperative Study. Arthritis Rheum 1996;39:2021-7.
23. Yli-Kerttula T, Luukkainen R, Yli-Kerttula U, Mottonen T, Hakola M, Korpela M, et al. Effect of a three month course of ciprofloxacin on the outcome of reactive arthritis. Ann Rheum Dis 2000;59:565-70.
24. Leirisalo-Repo M. Prognosis, course of disease, and treatment of the spondyloarthropathies. Rheum Dis Clin North Am 1998;24:737-51, viii.
25. Mijiyawa M, Oniankitan O, Khan MA. Spondyloarthropathies in sub-Saharan Africa. Curr Opin Rheumatol 2000;12:281-6.
26. Gladman DD, Pahman P. Psoriatic arthritis. In: Ruddy S, Harris ED Jr, Sledge CB, eds. Kelley's Textbook of rheumatology. 6th ed. Philadelphia: Saunders, 2001:1071-80.
27. Moll JM, Wright V. Psoriatic arthritis. Semin Arthritis Rheum 1973;3:55-78.
28. Combe B, Goupille P, Kuntz JL, Tebib J, Liote F, Bregeon C. Sulphasalazine in psoriatic arthritis: a randomized, multicentre, placebo-controlled study. Br J Rheumatol 1996;35:664-8.
29. Spadaro A, Riccieri V, Sili-Scavalli A, Sensi F, Taccari E, Zoppini A. Comparison of cyclosporin A and methotrexate in the treatment of psoriatic arthritis: a one-year prospective study. Clin Exp Rheumatol 1995;13:589-93.
30. Ory P, Sharp JJ, Salonen D, Rubenstein J, Mease PJ, Kivitz AJ, et al. Etanercept (ENBREL) inhibits radiographic progression in patients with psoriatic arthritis [Abstract]. Abstracts of the American College of Rheumatology 66th annual meeting and the Association of Rheumatology Health Professionals 37th annual meeting. October 24-29, 2002. New Orleans, Louisiana, USA. Arthritis Rheum 2002;46(9 suppl):S196.
31. De Vos M, Mielants H, Cuvelier C, Elewaut A, Veys E. Long-term evolution of gut inflammation in patients with spondyloarthropathy. Gastroenterology 1996;110:1696-703.